BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19560730)

  • 1. Predictors of 3-year mortality in institutionalized nonagenarians: the NonaSantfeliu study.
    Formiga F; Riera-Mestre A; Chivite D; Pujol R; Ferrer A; Lopéz-Soto A
    J Am Med Dir Assoc; 2009 Jul; 10(6):444-6. PubMed ID: 19560730
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive items of one-year mortality in nonagenarians. The NonaSantfeliu Study.
    Formiga F; Ferrer A; Mascaró J; Ruiz D; Olmedo C; Pujol R
    Aging Clin Exp Res; 2007 Aug; 19(4):265-8. PubMed ID: 17726355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of long-term survival in nonagenarians: the NonaSantfeliu study.
    Formiga F; Ferrer A; Chivite D; Rubio-Rivas M; Cuerpo S; Pujol R
    Age Ageing; 2011 Jan; 40(1):111-6. PubMed ID: 20823123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive items of 2-year mortality in nonagenarians with cognitive impairment at baseline: the NonaSantfeliu study.
    Formiga F; Ferrer A; Duaso E; Pujol R
    Arch Gerontol Geriatr; 2009; 48(2):254-7. PubMed ID: 18339437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of two-year mortality in nonagenarians with severe functional impairment at baseline: the NonaSantfeliu study.
    Formiga F; Ferrer A; Duaso E; Pujol R
    Age Ageing; 2008 Jan; 37(1):104-7. PubMed ID: 17956881
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictive items of functional decline and 2-year mortality in nonagenarians--the NonaSantfeliu study.
    Ferrer A; Formiga F; Ruiz D; Mascaró J; Olmedo C; Pujol R
    Eur J Public Health; 2008 Aug; 18(4):406-9. PubMed ID: 18519307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for functional decline in nonagenarians: a one-year follow-up. The NonaSantfeliu study.
    Formiga F; Ferrer A; Pérez-Castejon JM; Olmedo C; Pujol R
    Gerontology; 2007; 53(4):211-7. PubMed ID: 17351324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frailty and mortality or incident disability in institutionalized older adults: the FINAL study.
    de la Rica-Escuín M; González-Vaca J; Varela-Pérez R; Arjonilla-García MD; Silva-Iglesias M; Oliver-Carbonell JL; Abizanda P
    Maturitas; 2014 Aug; 78(4):329-34. PubMed ID: 24929996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vital status after five-year follow-up of nonagenarians with functional and/or cognitive impairment at baseline: the NonaSantfeliu study.
    Formiga F; Ferrer A; Rodriguez Molinero A; Fraga A; Cuerpo S; Pujol R
    J Nutr Health Aging; 2011 Feb; 15(2):121-5. PubMed ID: 21365165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The NonaSantfeliu study. Baseline assessment and ten years of follow-up].
    Formiga F; Ferrer A; Lombarte I; Fernández C
    Rev Esp Geriatr Gerontol; 2015; 50(3):143-9. PubMed ID: 24854969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Falls in nonagenarians after 1-year of follow-up: the NonaSantfeliu study.
    Formiga F; Ferrer A; Duaso E; Olmedo C; Pujol R
    Arch Gerontol Geriatr; 2008; 46(1):15-23. PubMed ID: 17382415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index as a predictor of all-cause mortality in nursing home residents during a 5-year follow-up.
    Veronese N; De Rui M; Toffanello ED; De Ronch I; Perissinotto E; Bolzetta F; D'Avanzo B; Cardin F; Coin A; Manzato E; Sergi G
    J Am Med Dir Assoc; 2013 Jan; 14(1):53-7. PubMed ID: 23141123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vitamin D levels and mortality of any cause in nonagenarians. NonaSantfeliu Study].
    Formiga F; Ferrer A; Fraga A; Pujol R
    Med Clin (Barc); 2011 Jun; 137(3):137-8. PubMed ID: 20207376
    [No Abstract]   [Full Text] [Related]  

  • 14. Community-dwelling nondisabled nonagenarians: two-year follow-up: the NonaSantfeliu Study.
    Formiga F; Ferrer A; Pérez-Castejon JM; Pujol R
    J Am Geriatr Soc; 2007 May; 55(5):801-3. PubMed ID: 17493207
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum high-density lipoprotein cholesterol levels, their relationship with baseline functional and cognitive status, and their utility in predicting mortality in nonagenarians.
    Formiga F; Ferrer A; Chivite D; Pinto X; Cuerpo S; Pujol R
    Geriatr Gerontol Int; 2011 Jul; 11(3):358-64. PubMed ID: 21241448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a prognostic index for 2-year mortality in Chinese older residents living in nursing homes.
    Chan TC; Shea YF; Luk KH; Chan HW; Chu LW
    Geriatr Gerontol Int; 2012 Jul; 12(3):555-62. PubMed ID: 22239701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cognitive assessment in nonagenarians. The NonaSantfeliu study].
    Formiga F; Ferrer A
    Rev Neurol; 2008 Dec 1-15; 47(11):616. PubMed ID: 19048545
    [No Abstract]   [Full Text] [Related]  

  • 18. Using mortality risk scores for long-term prognosis of nursing home residents: caution is recommended.
    Kruse RL; Parker Oliver D; Mehr DR; Petroski GF; Swenson DL; Zweig SC
    J Gerontol A Biol Sci Med Sci; 2010 Nov; 65(11):1235-41. PubMed ID: 20639529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of mortality in men and women aged 90 and older: a nine-year follow-up study in the Vitality 90+ study.
    Tiainen K; Luukkaala T; Hervonen A; Jylhä M
    Age Ageing; 2013 Jul; 42(4):468-75. PubMed ID: 23486170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is nursing home residence an independent risk factor of mortality in Chinese older adults?
    Chan TC; Hung IF; Cheng VC; Luk JK; Woo PC; Chu LW; Chan FH
    J Am Geriatr Soc; 2013 Aug; 61(8):1430-2. PubMed ID: 23937502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.